PIMJS
PKO Investment Management Joint-Stock Portfolio holdings
AUM
$931M
1-Year Return
16.38%
This Quarter Return
+5.05%
1 Year Return
+16.38%
3 Year Return
+65%
5 Year Return
+112.48%
10 Year Return
+522.82%
AUM
$811M
AUM Growth
+$1.28M
(+0.16%)
Cap. Flow
-$37.1M
Cap. Flow
% of AUM
-4.58%
Top 10 Holdings %
Top 10 Hldgs %
56.73%
Holding
168
New
4
Increased
40
Reduced
50
Closed
12
Top Buys
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
$18.8M |
| 2 |
Microsoft
MSFT
|
$4.73M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$4.15M |
| 4 |
DexCom
DXCM
|
$3.82M |
| 5 |
Lam Research
LRCX
|
$3.1M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$33.2M |
| 2 |
Mastercard
MA
|
$3.53M |
| 3 |
Visa
V
|
$3.41M |
| 4 |
Nike
NKE
|
$2.83M |
| 5 |
Newmont
NEM
|
$2.78M |
Sector Composition
| 1 | Materials | 17.01% |
| 2 | Technology | 12.73% |
| 3 | Healthcare | 7.5% |
| 4 | Consumer Discretionary | 5.75% |
| 5 | Energy | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
EQT Corp
EQT
$32.3B
| $740K | 0.09% |
20,200
+9,000
| +80% | +$330K |
|
127
Stryker
SYK
$151B
| $723K | 0.09% |
2,000
-6,368
| -76% | -$2.3M |
|
128
Signet Jewelers
SIG
$3.73B
| $722K | 0.09% |
7,000
| – | – |
|
129
Fortuna Silver Mines
FSM
$2.39B
| $718K | 0.09% |
154,377
-80,000
| -34% | -$372K |
|
130
Norwegian Cruise Line
NCLH
$11.6B
| $718K | 0.09% |
35,000
-10,000
| -22% | -$205K |
|
131
Reliance Steel & Aluminium
RS
$15.5B
| $713K | 0.09% |
2,464
+700
| +40% | +$202K |
|
132
Coterra Energy
CTRA
$18.6B
| $695K | 0.09% |
29,000
| – | – |
|
133
Steel Dynamics
STLD
$19.3B
| $630K | 0.08% |
5,000
+900
| +22% | +$113K |
|
134
Zoetis
ZTS
$67.9B
| $586K | 0.07% |
3,000
-1,000
| -25% | -$195K |
|
135
CF Industries
CF
$13.6B
| $575K | 0.07% |
6,700
+2,000
| +43% | +$172K |
|
136
Texas Pacific Land
TPL
$21.4B
| $557K | 0.07% |
630
| – | – |
|
|
MRO
137
DELISTED
Marathon Oil Corporation
MRO
| $556K | 0.07% |
20,861
| – | – |
|
138
PVH
PVH
$4.29B
| $555K | 0.07% |
5,500
| – | – |
|
139
Rivian
RIVN
$16.6B
| $505K | 0.06% |
45,000
-13,000
| -22% | -$146K |
|
140
RH
RH
$4.41B
| $502K | 0.06% |
1,500
| – | – |
|
141
Ovintiv
OVV
$10.9B
| $479K | 0.06% |
12,500
+3,500
| +39% | +$134K |
|
142
Teladoc Health
TDOC
$1.35B
| $459K | 0.06% |
50,000
| – | – |
|
143
Boston Scientific
BSX
$159B
| $419K | 0.05% |
5,000
| – | – |
|
144
Moderna
MRNA
$9.45B
| $401K | 0.05% |
6,000
+4,300
| +253% | +$287K |
|
145
Incyte
INCY
$16.7B
| $397K | 0.05% |
6,000
| – | – |
|
146
IQVIA
IQV
$31.3B
| $355K | 0.04% |
1,500
-1,500
| -50% | -$355K |
|
147
Idexx Laboratories
IDXX
$51.2B
| $354K | 0.04% |
700
-700
| -50% | -$354K |
|
148
Veeva Systems
VEEV
$44.3B
| $336K | 0.04% |
1,600
-8,000
| -83% | -$1.68M |
|
149
Baxter International
BAX
$12.1B
| $304K | 0.04% |
8,000
-10,000
| -56% | -$380K |
|
150
The Mosaic Company
MOS
$10.4B
| $295K | 0.04% |
11,000
| – | – |
|